Creative Medical Technology Holdings, Inc. (CELZ) - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2025 Annual Meeting of Stockholders held on December 18, 2025. The Company is incorporated in Nevada and its common stock trades on The Nasdaq Stock Market LLC under the symbol CELZ.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A quorum was established with 1,589,800 shares (61.5% of outstanding shares) present. The following proposals were voted upon:
- Proposal I (Election of Directors): All five nominees were elected. Vote counts ranged from approximately 419,951 to 434,834 "For" votes, with "Withhold" votes ranging from 41,443 to 56,326.
- Proposal II (Executive Compensation): The compensation of named executive officers was approved with 335,623 "For" votes, 108,092 "Against" votes, and 32,561 abstentions. There were 1,113,524 broker non-votes.
- Proposal III (Auditor Ratification): The appointment of Haynie & Company as independent registered public accountants was ratified with 1,346,871 "For" votes, 115,979 "Against" votes, and 126,950 abstentions.
Guidance, Outlook, and Risks
The filing does not provide management commentary, financial guidance, outlook, or specific risk factors. It serves solely to disclose the outcome of the shareholder vote.
Key Facts for Investor Verification
- Verify the final composition of the Board of Directors following the election of the five nominees.
- Confirm the high number of broker non-votes (1,113,524) on the executive compensation proposal and its implications for future proxy voting.
- Review the definitive Proxy Statement filed on October 30, 2025, for detailed biographies of the elected directors and specifics of the executive compensation package.
- Note that the filing contains no financial data; refer to the most recent 10-K or 10-Q for financial health metrics.